Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Operating Expenses: 2012-2016

Historic Operating Expenses for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2016 value amounting to $58.5 million.

  • Tvardi Therapeutics' Operating Expenses rose 10.05% to $13.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $68.1 million, marking a year-over-year increase of 48.45%. This contributed to the annual value of $58.5 million for FY2016, which is 101.74% up from last year.
  • Latest data reveals that Tvardi Therapeutics reported Operating Expenses of $58.5 million as of FY2016, which was up 101.74% from $29.0 million recorded in FY2015.
  • In the past 5 years, Tvardi Therapeutics' Operating Expenses registered a high of $58.5 million during FY2016, and its lowest value of $7.4 million during FY2012.
  • Its 3-year average for Operating Expenses is $36.2 million, with a median of $29.0 million in 2015.
  • Data for Tvardi Therapeutics' Operating Expenses shows a peak YoY skyrocketed of 101.74% (in 2016) over the last 5 years.
  • Over the past 5 years, Tvardi Therapeutics' Operating Expenses (Yearly) stood at $7.4 million in 2012, then surged by 64.30% to $12.2 million in 2013, then soared by 74.16% to $21.2 million in 2014, then skyrocketed by 36.43% to $29.0 million in 2015, then soared by 101.74% to $58.5 million in 2016.